Navigating Swissmedic procedures: expert insights to optimize marketing authorization applications for pharmaceutical companies
- Michael Zürcher
- Nov 20, 2024
- 1 min read
An interview with Katharina Oehler - part two
In the first part of our interview with Katharina Oehler (CEO of Pharma Services Oehler GmbH) we discussed the benefits, regulatory submission requirements and process for marketing authorization via the ACCESS Consortium. Now, in part two, we explore the numerous strategic considerations and decisions needed before submitting the dossier to Swissmedic. Thank you very much for the valuable insights, Ms. Oehler!
Download the interview:
About Swizzard Pharma AG
Swizzard Pharma AG is a provider of support services for biotech and pharma companies in Switzerland. As part of the company’s mission to enable healthy lives in Switzerland, Swizzard helps clients maximize the value of their medical breakthroughs in the Swiss market. Swizzard offers a range of services, drawing on vast experience and exceptional connections to deliver fast and lean settle-in, market preparation and commercialization solutions. CEO of Swizzard is Michael Zürcher, an experienced general manager in the life sciences industry.
Comments